Indeed, we also observed that FACS-sorted CD44+ cells showed an upregulation of SOX2 expression and demonstrated its important role in modulating the CD44+ population growth and the properties of CSCs in colorectal cancer using both knockdown and overexpression of SOX2, which is consistent with previous reports. The gene discussed is SOX2; the disease is colorectal cancer.